16729-0298
Ondansetron
Ondansetron
Injection
Intramuscular
Intravenous
Ondansetron
2.0
mg/mL
16729-0298-05
20 mL in 1 VIAL (16729-298-05)
Oct. 20, 2016
Ancillary Therapy
Antiemetic
5HT3 Receptor Antagonist
 
 
In Use